Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Fluarix TM
BIOLOGICAL
2 trials
Sponsors
GlaxoSmithKline
Conditions
Influenza
Phase 2
Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate
Completed
NCT00321763
GlaxoSmithKline
Influenza
Start: 2006-04-27
End: 2006-07-07
Updated: 2018-06-08
Phase 3
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
Completed
NCT00753272
GlaxoSmithKline
Influenza
Start: 2008-09-15
End: 2011-01-05
Updated: 2018-06-08
Related Papers
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and <i>post-hoc</i> correlate of protection analysis
Human Vaccines & Immunotherapeutics
2016-10-03
10 citations
Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines.
2014-04-04
24 citations
Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.
2013-07-26
30 citations
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.
2013-03-19
120 citations